TY - JOUR
T1 - Intracranial microvascular decompression for "cryptogenic" hemifacial spasm, tirgeminal and glossopharyngeal neuralgia, paroxysmal vertigo and tinnitus
T2 - II. Clinical study and long-term follow up
AU - Michelucci, R.
AU - Tassinari, C. A.
AU - Samoggia, G.
AU - Tognetti, F.
AU - Calbucci, F.
PY - 1986/6
Y1 - 1986/6
N2 - 20 patients who had undergone microvascular decompression for the treatment of "idiopathic" trigeminal neuralgia (9 cases), hemifacial spasm, (7 cases), glossopharyngeal neuralgia (3 cases) and paroxysmal vertigo and tinnitus (1 case) were followed up for 25 months on average. Permanent relief of symptoms was observed in 19 (95%), with sparing of cranial nerve function. Analysis of the clinical data shows that the patients described in the present series did not differ from those considered to suffer from "idiopathic" cranial nerve dysfunction syndromes. The importance of vascular cross compression as etiological factor in such conditions is stressed and the pathophysiology discussed. The term "cryptogenic" applied to trigeminal neuralgia or hemifacial spasm thus needs revising. Lastly, the indications of microvascular decompression in the treatment of "cryptogenic" cranial nerve dysfunction syndromes are defined.
AB - 20 patients who had undergone microvascular decompression for the treatment of "idiopathic" trigeminal neuralgia (9 cases), hemifacial spasm, (7 cases), glossopharyngeal neuralgia (3 cases) and paroxysmal vertigo and tinnitus (1 case) were followed up for 25 months on average. Permanent relief of symptoms was observed in 19 (95%), with sparing of cranial nerve function. Analysis of the clinical data shows that the patients described in the present series did not differ from those considered to suffer from "idiopathic" cranial nerve dysfunction syndromes. The importance of vascular cross compression as etiological factor in such conditions is stressed and the pathophysiology discussed. The term "cryptogenic" applied to trigeminal neuralgia or hemifacial spasm thus needs revising. Lastly, the indications of microvascular decompression in the treatment of "cryptogenic" cranial nerve dysfunction syndromes are defined.
KW - "Cryptogenic" cranial nerve dysfunction syndromes
KW - glossopharyngeal neuralgia
KW - hemifacial spasm
KW - intracranial microvascular decompression
KW - long-term results
KW - paroxysmal vertigo and tinnitus
KW - trigeminal neuralgia
UR - http://www.scopus.com/inward/record.url?scp=0022727818&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022727818&partnerID=8YFLogxK
U2 - 10.1007/BF02340877
DO - 10.1007/BF02340877
M3 - Article
C2 - 3733417
AN - SCOPUS:0022727818
VL - 7
SP - 367
EP - 374
JO - Italian Journal of Neurological Sciences
JF - Italian Journal of Neurological Sciences
SN - 0392-0461
IS - 3
ER -